213 related articles for article (PubMed ID: 15649646)
1. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress.
Trougakos IP; Gonos ES
Ann N Y Acad Sci; 2004 Jun; 1019():206-10. PubMed ID: 15247015
[TBL] [Abstract][Full Text] [Related]
3. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.
Lourda M; Trougakos IP; Gonos ES
Int J Cancer; 2007 Feb; 120(3):611-22. PubMed ID: 17096323
[TBL] [Abstract][Full Text] [Related]
4. Clusterin/Apolipoprotein J up-regulation after zinc exposure, replicative senescence or differentiation of human haematopoietic cells.
Trougakos IP; Pawelec G; Tzavelas C; Ntouroupi T; Gonos ES
Biogerontology; 2006; 7(5-6):375-82. PubMed ID: 16955214
[TBL] [Abstract][Full Text] [Related]
5. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
6. Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.
Trougakos IP; Gonos ES
Adv Cancer Res; 2009; 104():171-210. PubMed ID: 19878777
[TBL] [Abstract][Full Text] [Related]
7. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.
Trougakos IP; Gonos ES
Free Radic Res; 2006 Dec; 40(12):1324-34. PubMed ID: 17090421
[TBL] [Abstract][Full Text] [Related]
8. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
[TBL] [Abstract][Full Text] [Related]
9. Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B; Orzechowski A
Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
[TBL] [Abstract][Full Text] [Related]
10. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
Trougakos IP
Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression levels of the senescence biomarker clusterin/apolipoprotein j in lymphocytes from healthy centenarians.
Trougakos IP; Petropoulou C; Franceschi C; Gonos ES
Ann N Y Acad Sci; 2006 May; 1067():294-300. PubMed ID: 16804001
[TBL] [Abstract][Full Text] [Related]
12. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress.
Trougakos IP; So A; Jansen B; Gleave ME; Gonos ES
Cancer Res; 2004 Mar; 64(5):1834-42. PubMed ID: 14996747
[TBL] [Abstract][Full Text] [Related]
13. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
14. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
15. Clusterin: a potential target for improving response to antiestrogens.
Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways.
Balantinou E; Trougakos IP; Chondrogianni N; Margaritis LH; Gonos ES
Free Radic Biol Med; 2009 May; 46(9):1267-74. PubMed ID: 19353783
[TBL] [Abstract][Full Text] [Related]
18. Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells.
Strocchi P; Smith MA; Perry G; Tamagno E; Danni O; Pession A; Gaiba A; Dozza B
Neurobiol Aging; 2006 Nov; 27(11):1588-94. PubMed ID: 16464517
[TBL] [Abstract][Full Text] [Related]
19. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.
Yang C; Yang S; Wood KB; Hornicek FJ; Schwab JH; Fondren G; Mankin H; Duan Z
Apoptosis; 2009 Jan; 14(1):124-33. PubMed ID: 19052873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
